Status:
UNKNOWN
Multimodal Magnetic Resonance Imaging Study on the Neural Mechanisms of Remission in Children With ADHD
Lead Sponsor:
Peking University Sixth Hospital
Collaborating Sponsors:
Hangzhou Normal University
Conditions:
ADHD
Eligibility:
All Genders
6-16 years
Brief Summary
Attention-deficit/hyperactivity disorder(ADHD) is highly prevalent among children and adolescents and often associated with poor long-term outcomes in adulthood. it is thus a serious public health pro...
Detailed Description
the main aim of the current study is to explore the mechanism of remission in children with ADHD treated by MPH or ATX. Baseline information including demographic information, clinical features includ...
Eligibility Criteria
Inclusion
- \- clinical diagnosis of ADHD, based on K-SADS-PL medication naive aged 6-16
Exclusion
- \- history of severe head injury (with coma) other severe physical problem or disease in nervous system intelligence quotient (IQ) \< 80
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05229627
Start Date
January 1 2016
End Date
December 31 2023
Last Update
February 8 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.